We herewith submit Notice of 49th Annual General Meeting of the Company.

Earnings call Transcript for Jagsonpal Pharmaceuticals Limited Q1FY 26 Earnings Conference call held on July 28, 2025 at 3:00 P.M.

The Board in its meeting held on 31st July, 2025 approved continuation of directorship of Mr. Nand Gopal Khaitan, Non Executive Non Independent Director post attaining age of 75 years, subject to the approval of members

The Board of Directors of the Company had held a meeting on Wednesday, 12th February, 2025 which had started at 4.00 PM and ended at 5.00 PM. This revised outcome is in addition to the one filed earlier, and pertains to appointment of Secretarial Auditor and Internal Auditor.

Newspaper Publication of AGM

Alteration to the Object Clause of the Memorandum of Association

Financial Results Q1 FY 2025-26

Copy of Newspaper publication

Financial Results attached